| Literature DB >> 28662146 |
Yilei Liu1, Martina Lardi1, Alessandro Pedrioli1, Leo Eberl1, Gabriella Pessi1.
Abstract
Burkholderia cenocepacia is a versatile opportunistic pathogen that survives in a wide variety of environments, which can be limited in nutrients such as nitrogen. We have previously shown that the sigma factor σ54 is involved in the control of nitrogen assimilation and virulence in B. cenocepacia H111. In this work, we investigated the role of the σ54 enhancer binding protein NtrC in response to nitrogen limitation and in the pathogenicity of H111. Of 95 alternative nitrogen sources tested the ntrC showed defects in the utilisation of nitrate, urea, L-citrulline, acetamide, DL-lactamide, allantoin and parabanic acid. RNA-Seq and phenotypic analyses of an ntrC mutant strain showed that NtrC positively regulates two important phenotypic traits: exopolysaccharide (EPS) production and motility. However, the ntrC mutant was not attenuated in C. elegans virulence.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28662146 PMCID: PMC5491218 DOI: 10.1371/journal.pone.0180362
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Nitrogen sources differentially utilised by the wild-type, ntrC mutant and the complemented strains.
Cells were grown at 37°C for 4 days with slow agitation in order to synchronize the growth. 3 independent cultures of each strain were tested with each N source. Columns and error bars indicate the average and the standard deviation of final OD600, respectively.
Fig 2Differential transcript expression in the ntrC mutant compared to the wild type.
MA plot showing the log2 fold change in transcript expression of B. cenocepacia H111 wild type and ntrC mutant strains grown under nitrogen limited conditions. The top regulated genes (p-value < 0.001, absolute log2 (Fold Change) > 1.5) are shown in color: genes with increased transcription in the ntrC mutant compared to the wild type are indicated in orange, down-regulated genes in green. The names of the genes of particular interest are labelled.
List of the 150 genes with statistically significant differential expression, comparing the expression profile of the ntrC mutant with the profile of the wild type (DE-Seq analysis, p-value < 10−20, absolute log2(Fold Change) > 2.3).
| Class | Locus ID | Orthologs J2315 | Description | Gene name | Log2 ntrC vs wt |
|---|---|---|---|---|---|
| Amino acid metabolism and transport | I35_0158 | BCAL0151 | Leucine-, isoleucine-, valine-, threonine-, and alanine-binding protein | -3.6 | |
| I35_1846 | BCAL1926 | Homoserine dehydrogenase | 2.8 | ||
| I35_4872 | BCAM0952 | Putrescine transport ATP-binding protein | -3.1 | ||
| I35_4873 | BCAM0953 | ABC transporter, periplasmic spermidine putrescine-binding protein | -3.1 | ||
| I35_5229 | BCAM1377 | ABC-type spermidine/putrescine transport | 4.0 | ||
| I35_7109 | BCAS0112 | ABC-type arginine/histidine transport | -5.2 | ||
| I35_7110 | BCAS0113 | Histidine ABC transporter, ATP-binding protein | -3.8 | ||
| I35_7447 | BCAS0409 | Zinc metalloprotease | 2.4 | ||
| I35_7737 | BCAS0574 | Glutamate transport ATP-binding protein | -4.3 | ||
| I35_7739 | BCAS0576 | amino acid ABC transporter, permease protein | na(m) | ||
| I35_7740 | BCAS0577 | ABC-type amino acid transport, periplasmic component | -10.1 | ||
| I35_7874 | BCAS0751 | Gamma-glutamyltranspeptidase | -4.8 | ||
| Carbohydrate metabolism and transport | |||||
| Cell wall, membrane, envelope biogenesis | I35_0402 | BCAL3473 | Outer membrane protein (porin) | -4.2 | |
| I35_0812 | BCAL3057 | Soluble lytic murein transglycosylase | 3.2 | ||
| I35_3042 | BCAL0624 | Outer membrane protein (porin) | -6.4 | ||
| I35_4371 | BCAM0478 | Glucosamine—fructose-6-phosphate | -5.0 | ||
| I35_5644 | BCAM1769 | D-alanyl-D-alanine dipeptidase | -4.5 | ||
| I35_7271 | BCAS0256 | Outer membrane protein (porin) | -3.2 | ||
| Cell motility | |||||
| I35_0139 | BCAL0132 | Chemotaxis protein methyltransferase | -2.5 | ||
| Coenzyme metabolism | I35_1039 | BCAL1047 | Pyridoxal kinase | -2.4 | |
| Defense mechanism | I35_3251 | BCAL0420 | Type I restriction-modification system, restriction subunit R | 2.9 | |
| Energy production and conversion | I35_1414 | BCAL1516 | Dihydrolipoamide succinyltransferase component | 2.9 | |
| I35_2268 | BCAL2344 | NADH ubiquinone oxidoreductase chain A | 2.4 | ||
| I35_3124 | BCAL0541 | Aminobutyraldehyde dehydrogenase | -2.7 | ||
| Inorganic ion transport and metabolism | |||||
| I35_5646 | BCAM1771 | Dipeptide transport system permease protein | -3.2 | ||
| I35_5693 | BCAM1814 | Cyclohexanone monooxygenase | -2.8 | ||
| Lipid metabolism | |||||
| Nucleotide metabolism and transport | I35_0495 | BCAL3380 | Allantoicase | -3.5 | |
| I35_0689 | BCAL3172 | Xanthine dehydrogenase, molybdenum binding | -3.1 | ||
| Post translational modifications | |||||
| I35_3125 | BCAL0540 | ATP-dependent protease domain protein | -4.1 | ||
| I35_5615 | BCAM1744 | Extracellular protease precursor | -2.3 | ||
| Secondary structures | I35_2997 | BCAL0668 | Dienelactone hydrolase and related enzymes | -2.6 | |
| Transcription and signal transduction | |||||
| I35_1574 | BCAL1663 | Serine protein kinase | -4.0 | ||
| I35_3013 | BCAL0652 | EAL domain protein | -7.2 | ||
| I35_4176 | BCAM0176 | Transcriptional regulator, AsnC family | -3.6 | ||
| I35_4382 | BCAM0489 | Mercuric resistance operon regulatory protein | -3.6 | ||
| I35_4535 | BCAM0639 | Two-component response regulator | -6.5 | ||
| I35_4613 | BCAM0715 | Signal transduction histidine kinase | 3.5 | ||
| I35_4653 | BCAM0754 | Transcriptional regulator, TetR family | -3.6 | ||
| I35_5643 | BCAM1768 | Transcriptional regulators | -6.1 | ||
| I35_5806 | BCAM1975 | Ethanolamine operon regulatory protein | -4.8 | ||
| Translation | I35_2322 | BCAL2395 | Cytoplasmic axial filament protein CafA and Ribonuclease G | -2.5 | |
| I35_2859 | BCAL0812 | Ribosome hibernation protein | -3.9 | ||
| Others | I35_0339 | BCAL0348 | Uncharacterized protein | 3.4 | |
| I35_0688 | BCAL3173 | Xanthine dehydrogenase, iron-sulfur cluster and FAD-binding subunit A | -3.0 | ||
| I35_1575 | BCAL1664 | Hypothetical protein | -3.4 | ||
| I35_1576 | BCAL1665 | SpoVR-like protein | -3.0 | ||
| I35_1588 | BCAL1677 | Type 1 fimbriae major subunit | 5.2 | ||
| I35_1881 | BCAL1961 | Ankyrin repeat protein | -2.5 | ||
| I35_2376 | BCAL2448 | Phenazine biosynthesis protein PhzF like | 3.1 | ||
| I35_2564 | BCAL2703 | Branched-chain amino acid transport ATP-binding protein | -2.4 | ||
| I35_3012 | BCAL0653 | Hypothetical protein | -4.3 | ||
| I35_3082 | BCAL0584 | Outer membrane porin | -3.3 | ||
| I35_4192 | BCAM0193 | Hypothetical protein | 6.0 | ||
| I35_4193 | BCAM0194 | Hypothetical protein | 5.9 | ||
| I35_4195 | BCAM0196 | Hypothetical protein | 4.7 | ||
| I35_4401 | BCAM0507 | Uncharacterized protein conserved in bacteria | -3.5 | ||
| I35_4471 | BCAM0576 | Hypothetical protein | -3.4 | ||
| I35_4651 | BCAM0752 | Hydrolase-related protein | -3.6 | ||
| I35_4652 | BCAM0753 | Hypothetical protein | -3.9 | ||
| I35_4669 | BCAM0770 | Hypothetical protein | -7.4 | ||
| I35_4943 | BCAM1098 | MutT/nudix family protein | -2.7 | ||
| I35_5153 | BCAM1304 | Phage-related protein | -2.4 | ||
| I35_5345 | BCAM1491 | Hypothetical protein | -4.8 | ||
| I35_5645 | BCAM1770 | Dipeptide-binding ABC transporter, periplasmic component | -4.8 | ||
| I35_5655 | BCAM1777A | Hypothetical protein | -3.6 | ||
| I35_5695 | BCAM1816 | Hypothetical protein | -2.7 | ||
| I35_5683 | BCAM1804 | Methyl-accepting chemotaxis protein | -2.9 | ||
| I35_5753 | BCAM1927 | Membrane-fusion protein | -3.1 | ||
| I35_6098 | BCAM2209 | Hypothetical protein | -3.0 | ||
| I35_6344 | BCAM2444 | Conserved domain protein | -4.1 | ||
| I35_6461 | BCAM2564 | Aerotaxis sensor receptor protein | -4.9 | ||
| I35_6515 | BCAM2618 | Histidine ABC transporter, histidine-binding periplasmic protein | -4.4 | ||
| I35_6573 | BCAM2679 | Hypothetical protein | -9.0 | ||
| I35_6574 | BCAM2680 | Putative exported protein | -3.6 | ||
| I35_6579 | Hypothetical protein | -4.6 | |||
| I35_7149 | Hypothetical protein | -3.7 | |||
| I35_7282 | BCAS0267a | 3',5'-cyclic-nucleotide phosphodiesterase | -4.7 | ||
| I35_7285 | BCAS0271 | Urea carboxylase-related aminomethyltransferase | na(m) | ||
| I35_7735 | BCAS0571 | Salicylate hydroxylase | -4.5 | ||
| I35_7815 | Ethanolamine operon regulatory protein | -4.2 | |||
aNomenclature and description according to GenBank file (accession no. HG938370, HG938371, and HG9383729).
bOrthologs were identified as described in the Material and Methods section.
cFold change (FC) of transcription, comparing ntrC mutant with wild type grown under nitrogen limited conditions.
na, not applicable because the read number in the mutant is equal to 0.
all the genes with an rpoN box in the promoter region are indicated in bold.
Validation of selected RNA-Seq results by qPCR.
| Locus ID | J2315 orthologs | Description | Gene name | Log2 FC MT vs WT | Log2 FC MT vs WT |
|---|---|---|---|---|---|
| I35_0767 | BCAL3106 | Urease alpha subunit | -5.0 | -5.2 | |
| I35_2151 | BCAL2223 | Glutamine synthetase | -3.6 | -4.8 | |
| I35_4771 | BCAM0858 | Polysaccharide export lipoprotein | -1.2 | -2.6 | |
| I35_4928 | BCAM1009 | O-antigen acetylase | -1.1 | -4 | |
| I35_6233 | BCAM2340 | 3-(3-hydroxyalkanoyloxy) alkanoic acids synthase | -1.6 | -2.9 | |
| I35_0133 | BCAL0126 | Flagellar motor rotation protein | -0.9 | -2.7 | |
| I35_3089 | BCAL0577 | Flagellar hook-associated protein | -2.4 | -2.9 | |
| I35_3103 | BCAL0561 | Flagellar biosynthesis protein | -1.8 | -3.3 |
aNomenclature and description according to GenBank file (accession no. HG938370, HG938371, and HG938372).
bOrthologs were identified as described in the Material and Methods section.
cFold change (FC) of transcription determined by qPCR, comparing the ntrC mutant (MT) with the wild type (WT) grown in AB minimal medium with a shift experiment. The standard deviation is less than 10% of the fold change.
dFold change (FC) of transcription determined by RNA-Seq, comparing the ntrC mutant (MT) with the wild type (WT) grown in AB minimal medium (shift experiment).
Fig 3NtrC–dependent EPS production.
EPS production in the wild type (1), the ntrC mutant (2) and the complemented strain (3) was tested on YEM plates. Three independent biological replicates were tested; the result of one is shown here.
Fig 4Biofilm formation is only slightly dependent on NtrC.
Biofilm production was assessed for the wild type, ntrC mutant and complemented strain in 96-well plates. The columns represent the mean biofilm index generated from independent biological triplicate cultures of each strain. The error bars indicate the standard deviation. The increased biofilm formation in the complemented mutant compared to the wild type was statistically significant (*** p<0.0001). However, the slight reduction in the mutant was not statistically significant (ns).
Fig 5NtrC–dependent motility.
The histograms show the swarming (A) and swimming (B) motility of the ntrC mutant and the complemented mutant relative to the wild-type strain H111. Both assays were performed in triplicate. Significance was calculated by comparing the mutant or the complemented mutant with the wild type (* p<0.05 and ** p<0.01).